{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:33:55Z","timestamp":1773293635352,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,17]]},"DOI":"10.7759\/cureus.31609","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:31:50Z","timestamp":1668702710000},"source":"Crossref","is-referenced-by-count":1,"title":["Familial Adenomatous Polyposis: Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Juan Jos\u00e9","family":"Chaves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Chaves-Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Parra-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Octavio","family":"Chaves-Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Familial adenomatous polyposis","author":"Wiik M","year":"2020","unstructured":"Wiik M, Talseth-Palmer B. . Familial adenomatous polyposis. Handbook of tumor syndromes. Liu D (ed): CRC Press, 2020. 137-49."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/jnccn.2021.0048","article-title":"NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: colorectal, version 1.2021","volume":"19","author":"Weiss JM","year":"2021","unstructured":"Weiss JM, Gupta S, Burke CA, et al.. NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: colorectal, version 1.2021. J Natl Compr Canc Netw. 2021, 19:1122-32. 10.1164\/jnccn.2021.0048","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.giec.2021.08.007","article-title":"Endoscopic management and surgical considerations for familial adenomatous polyposis","volume":"32","author":"Stanich PP","year":"2022","unstructured":"Stanich PP, Sullivan B, Kim AC, Kalady MF. Endoscopic management and surgical considerations for familial adenomatous polyposis. Gastrointest Endosc Clin N Am. 2022, 32:113-30. 10.1016\/j.giec.2021.08.007","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-021-00197-8","article-title":"Danish guidelines for management of non-APC-associated hereditary polyposis syndromes","volume":"19","author":"Jelsig AM","year":"2021","unstructured":"Jelsig AM, Karstensen JG, Jespersen N, et al.. Danish guidelines for management of non-APC-associated hereditary polyposis syndromes. Hered Cancer Clin Pract. 2021, 19:41. 10.1186\/s13053-021-00197-8","journal-title":"Hered Cancer Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal S","year":"2015","unstructured":"Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015, 110:223-62. 10.1038\/ajg.2014.435","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG)","volume":"69","author":"Monahan KJ","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, et al.. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020, 69:411-44. 10.1136\/gutjnl-2019-319915","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/a-1521-4912","article-title":"Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?","volume":"9","author":"van Leerdam ME","year":"2021","unstructured":"van Leerdam ME, Latchford A. Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?. Endosc Int Open. 2021, 9:E1445-6. 10.1055\/a-1521-4912","journal-title":"Endosc Int Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/a-1467-6257","article-title":"Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis","volume":"9","author":"Pasquer A","year":"2021","unstructured":"Pasquer A, Benech N, Pioche M, et al.. Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis. Endosc Int Open. 2021, 9:E1014-22. 10.1055\/a-1467-6257","journal-title":"Endosc Int Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.570241","article-title":"Immune microenvironment: new insight for familial adenomatous polyposis","volume":"11","author":"Yang J","year":"2021","unstructured":"Yang J, Wen Z, Li W, et al.. Immune microenvironment: new insight for familial adenomatous polyposis. Front Oncol. 2021, 11:570241. 10.3389\/fonc.2021.570241","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-020-00189-y","article-title":"Chemoprevention in familial adenomatous polyposis: past, present and future","volume":"20","author":"Kemp Bohan PM","year":"2021","unstructured":"Kemp Bohan PM, Mankaney G, Vreeland TJ, et al.. Chemoprevention in familial adenomatous polyposis: past, present and future. Fam Cancer. 2021, 20:23-33. 10.1007\/s10689-020-00189-y","journal-title":"Fam Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916063","article-title":"Eflornithine plus sulindac for prevention of progression in familial adenomatous polyposis","volume":"383","author":"Burke CA","year":"2020","unstructured":"Burke CA, Dekker E, Lynch P, et al.. Eflornithine plus sulindac for prevention of progression in familial adenomatous polyposis. N Engl J Med. 2020, 383:1028-39. 10.1056\/NEJMoa1916063","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10010005","article-title":"Oncogenic signalling through mechanistic target of papamycin (mTOR): a driver of metabolic transformation and cancer progression","volume":"10","author":"Rad E","year":"2018","unstructured":"Rad E, Murray JT, Tee AR. Oncogenic signalling through mechanistic target of papamycin (mTOR): a driver of metabolic transformation and cancer progression. Cancers (Basel). 2018, 10:5. 10.3390\/cancers10010005","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000497","article-title":"Sirolimus for the treatment of polyposis of the rectal remnant and ileal pouch in four patients with familial adenomatous polyposis: a pilot study","volume":"7","author":"Roos VH","year":"2020","unstructured":"Roos VH, Meijer BJ, Kallenberg FG, et al.. Sirolimus for the treatment of polyposis of the rectal remnant and ileal pouch in four patients with familial adenomatous polyposis: a pilot study. BMJ Open Gastroenterol. 2020, 7:e000497. 10.1136\/bmjgast-2020-000497","journal-title":"BMJ Open Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0580","article-title":"The effect of metformin in treatment of adenomas in patients with familial adenomatous polyposis","volume":"14","author":"Park JJ","year":"2021","unstructured":"Park JJ, Kim BC, Hong SP, et al.. The effect of metformin in treatment of adenomas in patients with familial adenomatous polyposis. Cancer Prev Res (Phila). 2021, 14:563-72. 10.1158\/1940-6207.CAPR-20-0580","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000555","article-title":"Imatinib: a new chemopreventive option in adenomatous polyposis?","volume":"7","author":"Tobon A","year":"2020","unstructured":"Tobon A, Olivas P, Oca\u00f1a T, Pellis\u00e9 M, Balaguer F. Imatinib: a new chemopreventive option in adenomatous polyposis?. BMJ Open Gastroenterol. 2020, 7:e000555. 10.1136\/bmjgast-2020-000555","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/125486-familial-adenomatous-polyposis-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:43Z","timestamp":1707508123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/125486-familial-adenomatous-polyposis-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.31609","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,17]]}}}